Read + Share
Amedeo Smart
Independent Medical Education
Sandrock A. Letter Concerning Medicare Should Not Cover Aducanumab as a Treatment for Alzheimer's Disease by Moghavem, Henderson, and Greicius. Ann Neurol 2021 Oct 23. doi: 10.1002/ana.26254.PMID: 34687454
Email
LinkedIn
Facebook
Twitter
Privacy Policy